The overall mission of the Biostatistics and Data Management Core (Core G) is to encourage and facilitate high quality innovative, interdisciplinary and translational HIV/AIDS research through effective data management and by supporting the use of rigorous statistical and analytic methodologies;provide educational opportunities for HIV/AIDS researchers on the Penn campus in the use of statistical approaches; assist in building capacity locally and with International partners;and support the overall strategic plan and mission of the Penn CFAR. To achieve these goals, the Specific Aims of the Biostatistics and Data Management Core G are to: A.1. Advise CFAR Investigators on study design and data analysis issues. A.2. Provide statistical collaboration for research funding applications. A.3. Maintain, and facilitate access to, a clinical care database for use in studying the epidemiology of HIV/AIDS, for evaluating feasibility of intervention studies and for facilitating conduct of such studies. A.4. Provide support for design and testing of data collection instruments, data management, and database development. A.5. Provide training in statistical methods to CFAR investigators and our international partners. A.6. Partner with other Cores and specific Programs of the CFAR in interdisciplinary initiatives as well as other CFARs in support of joint goals.
Core G supports CFAR investigators'ability to carry out high quality innovative and translational research by maintaining a clinical database and by providing expertise and education in study design and the use of rigorous statistical and analytical techniques.
|Gross, Robert; Bandason, Tsitsi; Langhaug, Lisa et al. (2015) Factors associated with self-reported adherence among adolescents on antiretroviral therapy in Zimbabwe. AIDS Care 27:322-6|
|Safren, Steven A; Biello, Katie B; Smeaton, Laura et al. (2014) Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS One 9:e104178|
|Muluneh, Melaku; Shang, Wu; Issadore, David (2014) Track-etched magnetic micropores for immunomagnetic isolation of pathogens. Adv Healthc Mater 3:1078-85|
|Wohl, David A; Arnoczy, Gretchen; Fichtenbaum, Carl J et al. (2014) Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther 19:141-7|
|Nachega, Jean B; Parienti, Jean-Jacques; Uthman, Olalekan A et al. (2014) Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis 58:1297-307|
|Zetola, Nicola M; Modongo, Chawangwa; Olabiyi, Bisayo et al. (2014) Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge. Sex Transm Infect 90:216-22|
|Haas, David W; Kwara, Awewura; Richardson, Danielle M et al. (2014) Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes. J Antimicrob Chemother 69:2175-82|
|Ramirez, Lorenzo A; Daniel, Alexander; Frank, Ian et al. (2014) Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells. J Infect Dis 210:646-50|
|Liu, Weimin; Li, Yingying; Shaw, Katharina S et al. (2014) African origin of the malaria parasite Plasmodium vivax. Nat Commun 5:3346|
|Blank, Michael B; Hennessy, Michael; Eisenberg, Marlene M (2014) Increasing quality of life and reducing HIV burden: the PATH+ intervention. AIDS Behav 18:716-25|
Showing the most recent 10 out of 235 publications